Allan Jordan

Views & Analysis

We speak to R&D experts to find out how oncology biotechs can get the support they need to be successful in the competitive UK ecosystem

News

Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.